---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295253321.md"
description: "Guardian Pharmacy Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, Oppenheimer maintained an Outperform rating on the stock and raised its price target from $43 to $49."
datetime: "2026-08-07T15:11:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295253321.md)
  - [en](https://longbridge.com/en/news/295253321.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295253321.md)
generator: "portal-rs"
---

# 

Guardian Pharmacy Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, Oppenheimer maintained an Outperform rating on the stock and raised its price target from $43 to $49.

### Related Stocks

- [GRDN.US](https://longbridge.com/en/quote/GRDN.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)

## Related News & Research

- [Guardian Pharmacy Q2 revenue beats estimates; 2026 outlook lifted](https://longbridge.com/en/news/295139279.md)
- [Sanctuary Advisors LLC Takes Position in Guardian Pharmacy Services, Inc. $GRDN](https://longbridge.com/en/news/293725651.md)
- [Will HDDs Be Replaced by SSDs? Investment Value Analysis of Seagate Technology and Western Digital in the AI Era](https://longbridge.com/en/news/300838673.md)
- [Constellation Brands Stock Forecast: Beer Demand Faces a Key Q2 Earnings Test](https://longbridge.com/en/news/300859275.md)
- [If I Could Only Buy 1 Space Stock for the Next Decade, It Wouldn't Be SpaceX or Rocket Lab](https://longbridge.com/en/news/300850222.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**